Latticework Capital Management (LCM) has announced the closing of its latest fund with $345 million in commitments.

The new fund, LCM Healthcare Fund II, was oversubscribed, with the firm originally target $275 million. The fund will pursue control investments in founder-led lower middle market healthcare companies.

Latticework, based in Dallas, makes control equity investments in the lower middle market. Founded in 2015, the firm focuses exclusively on healthcare, specifically the provider services, hospital/major facilities, life sciences/pharmaceutical (pharmaceutical services and contract manufacturing for medical equipment/devices) and non-reimbursement industries. Latticework prefers to make more substantial investments from a dollars perspective.